Joel Isaacson & Co., LLC - HEMISPHERX BIOPHARMA INC ownership

HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C103. A total of 23 filers reported holding HEMISPHERX BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Joel Isaacson & Co., LLC ownership history of HEMISPHERX BIOPHARMA INC
ValueSharesWeighting
Q4 2014$4,000
-20.0%
15,5000.0%0.00%
-50.0%
Q3 2014$5,0000.0%15,5000.0%0.00%0.0%
Q2 2014$5,000
-16.7%
15,5000.0%0.00%0.0%
Q1 2014$6,000
+50.0%
15,5000.0%0.00%
+100.0%
Q4 2013$4,000
-42.9%
15,500
-49.2%
0.00%
-66.7%
Q3 2013$7,0000.0%30,5000.0%0.00%0.0%
Q2 2013$7,0000.0%30,500
-17.2%
0.00%
-25.0%
Q1 2013$7,000
-22.2%
36,8400.0%0.00%
-33.3%
Q4 2012$9,00036,8400.01%
Other shareholders
HEMISPHERX BIOPHARMA INC shareholders Q1 2015
NameSharesValueWeighting ↓
Occidental Asset Management, LLC 190,000$521,0000.65%
WEDBUSH SECURITIES INC 80,000$18,0000.00%
CITY HOLDING CO 5,000$1,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 290,000$66,120,0000.00%
WELLS FARGO & COMPANY/MN 20,792$4,0000.00%
NORTHERN TRUST CORP 235,051$53,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 897,977$204,0000.00%
STATE STREET CORP 81,000$18,0000.00%
GUGGENHEIM CAPITAL LLC 37,501$9,0000.00%
GOLDMAN SACHS GROUP INC 24,735$6,0000.00%
View complete list of HEMISPHERX BIOPHARMA INC shareholders